POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF VORINOSTAT IN PATIENTS WITH ADVANCED SOLID TUMORS WITH VARYING DEGREES OF HEPATIC FUNCTION.

Yang H.; Ramalingam S.; Kummar S.; Harvey R.; Ivy P.; Beumer J.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF VORINOSTAT IN PATIENTS WITH ADVANCED SOLID TUMORS WITH VARYING DEGREES OF HEPATIC FUNCTION.

【24h】

POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF VORINOSTAT IN PATIENTS WITH ADVANCED SOLID TUMORS WITH VARYING DEGREES OF HEPATIC FUNCTION.

机译：肝功能各不相同的高级实体瘤患者的伏立诺他人群的药动学和药动学分析。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2015年第s1期|共2页
作者
Yang H.; Ramalingam S.; Kummar S.; Harvey R.; Ivy P.; Beumer J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF VORINOSTAT IN PATIENTS WITH ADVANCED SOLID TUMORS WITH VARYING DEGREES OF HEPATIC FUNCTION. [J] . Yang H., Ramalingam S., Kummar S., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：肝功能各不相同的高级实体瘤患者的伏立诺他人群的药动学和药动学分析。
2. Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Dysfunction [J] . Zhou Xiaofei, Lockhart A. Craig, Fu Siqing, The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology . 2019,第9期

机译：研究Aurora的药代动力学是成年患者的激酶抑制剂Alisentib或具有不同程度的肝功能障碍复发/难治性淋巴瘤
3. Pharmacokinetics (PK) of alisertib (MLN8237) in adult patients (pts) with advanced solid tumors or relapsed/refractory lymphoma with varying degrees of hepatic function [J] . Zhou X., Lockhart A. C., Fu S., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：患有不同程度肝功能的晚期实体瘤或复发/难治性淋巴瘤成年患者（pts）中alisertib（MLN8237）的药代动力学（PK）
4. In silico assessment of nifedipine effects on human heart cells: Pharmacokinetic-pharmacodynamic analyses at the population level [C] . Mitra Abbasi, Sebastian Polak Computing in Cardiology Conference . 2017

机译：硝苯地平对人体心脏细胞影响的计算机评估：人群水平的药代动力学-药效学分析
5. Evaluation of the pharmacokinetic-pharmacodynamic relationship, metabolism and plasma protein binding of the novel antitumor agent, 2-methoxyestradiol (2ME2), following oral administration in patients with solid tumors. [D] . Lakhani, Nehal Jagdish. 2005

机译：实体瘤患者口服后评估新型抗肿瘤药2-甲氧基雌二醇（2ME2）的药代动力学与药效关系，代谢和血浆蛋白结合。
6. A Phase I Pharmacokinetic and Pharmacodynamic Study of Two Schedules of Vorinostat in Combination with 5-Fluorouracil and Leucovorin in Patients with Refractory Solid Tumors [O] . Marwan G. Fakih, Gerald Fetterly, Merrill J. Egorin, -1

机译：I期药代动力学以及在与5-氟尿嘧啶和亚叶酸钙联合伏立诺他的两个时间表药效学研究中的患者难治性实体瘤
7. Pharmacokinetic and Pharmacodynamic Analysis of Circulating Biomarkers of Anti-NRP1, a Novel Antiangiogenesis Agent, in Two Phase I Trials in Patients with Advanced Solid Tumors [O] . Yan Xin, Jessica Li, Jenny Wu, 2012

机译：抗NRP1，一种新型抗脑发生剂循环生物标志物的药代动力学和药效学分析，治疗晚期实体肿瘤患者的两阶段试验中

POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF VORINOSTAT IN PATIENTS WITH ADVANCED SOLID TUMORS WITH VARYING DEGREES OF HEPATIC FUNCTION.

著录项

相似文献

相关主题

期刊订阅